Europe Biosurgery Lines Competition, Opportunities and Challenges 2021-2026

[hemlata kumbhar]

Europe biosurgery market accounted for $3,610.6 million in 2020 and will grow by 6.2% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.
ALSO READ: http://www.marketwatch.com/story/europe-biosurgery-market-research-...
Highlighted with 34 tables and 50 figures, this 104-page report “Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Europe biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country.
ALSO READ: http://www.marketwatch.com/story/gaming-simulators-market-research-...
Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Hemostatic Agents
• Bone-graft Substitutes
o Synthetic Graft Extender
o Demineralized Bone Matrix
o Bone Morphogenetic Proteins
o Cell-Based Matrices
• Surgical Sealants and Adhesives
o Natural Surgical Sealing Agents
o Synthetic Surgical Sealing Agents
• Soft-tissue Attachments
o Natural & Biological Mesh/Patch
o Synthetic Mesh/Patch
• Adhesion Barriers
o Natural Adhesion Barriers
o Synthetic Adhesion Barriers
• Staple Line Reinforcement

Based on Source Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Natural/Biological Products
• Synthetic Products
ALSO READ: http://www.marketwatch.com/story/non-peanut-nut-butters-market-rese...
Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Other Applications

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
ALSO READ: http://www.marketwatch.com/story/high-pressure-vessels-market-resea...
Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
ALSO READ: http://www.marketwatch.com/story/neuro-stimulators-market-research-...
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34
3 Segmentation of Europe Market by Product 38
3.1 Market Overview by Product 38
3.2 Hemostatic Agents 40
3.3 Bone-graft Substitutes 41
3.2.1 Synthetic Graft Extender 42
3.2.2 Demineralized Bone Matrix 43
3.2.3 Bone Morphogenetic Proteins 44
3.2.4 Cell-Based Matrices 45
3.4 Surgical Sealants and Adhesives 46
3.4.1 Natural Surgical Sealing Agents 47
3.4.2 Synthetic Surgical Sealing Agents 48
3.5 Soft-tissue Attachments 49
3.5.1 Natural & Biological Mesh/Patch 50
3.5.2 Synthetic Mesh/Patch 51
3.6 Adhesion Barriers 52
3.6.1 Natural Adhesion Barriers 53
3.6.2 Synthetic Adhesion Barriers 54
3.7 Staple Line Reinforcement 55
4 Segmentation of Europe Market by Source Type 56
4.1 Market Overview by Source Type 56
4.2 Natural/Biological Products 58
4.3 Synthetic Products 59
5 Segmentation of Europe Market by Application 61
5.1 Market Overview by Application 61
5.2 Orthopedic Surgery 63
5.3 General Surgery 64
5.4 Neurological Surgery 65
5.5 Cardiovascular Surgery 66
5.6 Gynecological Surgery 67
5.7 Other Applications 68
6 European Market 2020-2027 by Country 69
6.1 Overview of European Market 69
6.2 UK 72
6.3 France 74
6.4 Germany 76
6.5 Spain 78
6.6 Italy 80
6.7 Russia 82
6.8 Rest of European Market 84
7 Competitive Landscape 86
7.1 Overview of Key Vendors 86
7.2 New Product Launch, Partnership, Investment, and M&A 89
7.3 Company Profiles 90
B. Braun Melsungen AG 90
Baxter International, Inc. 92
Becton, Dickinson and Company (C.R. Bard) 93
Betatech Medical 94
CryoLife Inc. 95
CSL Limited 96
Hemostasis LLC 97
Integra Lifesciences Holdings Corporation 98
Johnson & Johnson 99
Medtronic PLC 100
Pfizer, Inc. 101
Sanofi S.A. 102
Stryker Corporation 103
RELATED REPORTS 104Table 1. Snapshot of Europe Biosurgery Market in Balanced Perspective, 2020-2027 17
Table 2. Growth Rate of World GDP, 2020-2022 20
Table 3. Main Product Trends and Market Opportunities in Europe Biosurgery Market 30
…..…continued
CONTACT DETAILS :
[e-mail]
[phone]
[phone]
971 0503084105